Rekombinanter PDCD1 (Pembrolizumab Biosimilar) Antikörper

Produktnummer ABIN7581619

This anti-PDCD1 (Pembrolizumab Biosimilar) antibody (ABIN7581619) is a Human Monoclonal antibody detecting PDCD1 (Pembrolizumab Biosimilar) in FACS, ELISA, BLI, Func, SPR. Suitable for Human.

Quick Overview for Rekombinanter PDCD1 (Pembrolizumab Biosimilar) Antikörper (ABIN7581619)

Target: PDCD1 (Pembrolizumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Human

Klonalität: Monoklonal

Konjugat: Dieser PDCD1 (Pembrolizumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), ELISA, Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Produktdetails anti-PDCD1 (Pembrolizumab Biosimilar) Antikörper

Expressionssystem: CHO Cells

Verwendungszweck: Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pembrolizumab)

Sequenz: QVQLVQSGVE VKKPGASVKV SCKASGYTFT NYYMYWVRQA PGQGLEWMGG INPSNGGTNF NEKFKNRVTL TTDSSTTTAY MELKSLQFDD TAVYYCARRD YRFDMGFDYW GQGTTVTVSS ASTKGPSVFP LAPCSRSTSE STAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS GLYSLSSVVT VPSSSLGTKT YTCNVDHKPS NTKVDKRVES KYGPPCPPCP APEFLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSQED PEVQFNWYVD GVEVHNAKTK PREEQFNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKGLPS SIEKTISKAK GQPREPQVYT LPPSQEEMTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSRL TVDKSRWQEG NVFSCSVMHE ALHNHYTQKS LSLSLGK,EIVLTQSPAT LSLSPGERAT LSCRASKGVS TSGYSYLHWY QQKPGQAPRL LIYLASYLES GVPARFSGSG SGTDFTLTIS SLEPEDFAVY YCQHSRDLPL TFGGGTKVEI KRTVAAPSVF IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC

Produktmerkmale: Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pembrolizumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Reinheit: >95 %

Isotyp: IgG4 S228P

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Kommentare:

Therapeutic Agents by Target and Mechanism: PD-1 inhibitors

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Lagerung: 4 °C,-80 °C

Informationen zur Lagerung: +4°C,-80°C

Details zu PDCD1 (Pembrolizumab Biosimilar)

Target: PDCD1 (Pembrolizumab Biosimilar)

Substanzklasse: Biosimilar

Molekulargewicht: 145.5 kDa

UniProt: Q15116